首页 > 最新文献

Experimental Diabetes Research最新文献

英文 中文
Associations of common variants at APLN and hypertension in Chinese subjects with and without diabetes. 中国有或无糖尿病受试者中常见的APLN变异与高血压的关系
Pub Date : 2012-01-01 Epub Date: 2012-12-17 DOI: 10.1155/2012/917496
Rong Zhang, Jingyi Lu, Cheng Hu, Congrong Wang, Weihui Yu, Feng Jiang, Shanshan Tang, Yuqian Bao, Kunsan Xiang, Weiping Jia

Background: Apelin, the endogenous ligand for the APJ receptor, has a potent hypotensive effect via a nitric oxide-dependent mechanism in vivo. The aim of the study was to investigate the association between the common variants of apelin gene (APLN) and hypertension, which was reported recently in a Chinese Han population with and without diabetes.

Methods: Three single nucleotide polymorphisms (SNPs) on APLN were genotyped in 3156 diabetic patients and 3736 nondiabetic individuals. For non-diabetic subjects, 1779 were enrolled in stage 1 and 1757 were recruited for validation. A meta-analysis combining the two stages was carried out to obtain the overall effect.

Results: In diabetic patients, no significant associations of the three SNPs with hypertension were observed. In contrast, we found that rs2235306 was associated with hypertension in non-diabetic males after adjusting for covariates (OR = 1.19, P = 0.039) while rs2235307 and rs3115759 displayed no evidence of association in both genders. One haplotype, C-C-A, also showed an association with hypertension (OR = 1.47, P = 0.032) only in men. However, analysis in stage 2 and meta-analysis did not support these findings.

Conclusions: We conclude that common variants on APLN are not associated with the prevalence of hypertension in the Chinese.

背景:APJ受体的内源性配体Apelin在体内通过一氧化氮依赖机制具有有效的降压作用。该研究的目的是调查最近在中国汉族人群中报道的有糖尿病和无糖尿病的apelin基因(APLN)常见变异与高血压之间的关系。方法:对3156例糖尿病患者和3736例非糖尿病患者进行APLN 3个单核苷酸多态性的基因分型。对于非糖尿病受试者,1779人入组第一阶段,1757人入组验证。结合这两个阶段进行荟萃分析以获得总体效果。结果:在糖尿病患者中,没有观察到这三个snp与高血压的显著相关性。相比之下,在调整协变量后,我们发现rs2235306与非糖尿病男性高血压相关(OR = 1.19, P = 0.039),而rs2235307和rs3115759在两性中均未显示相关性。单倍型C-C-A也仅在男性中与高血压相关(OR = 1.47, P = 0.032)。然而,第二阶段的分析和荟萃分析并不支持这些发现。结论:我们得出结论,APLN的常见变异与中国高血压患病率无关。
{"title":"Associations of common variants at APLN and hypertension in Chinese subjects with and without diabetes.","authors":"Rong Zhang,&nbsp;Jingyi Lu,&nbsp;Cheng Hu,&nbsp;Congrong Wang,&nbsp;Weihui Yu,&nbsp;Feng Jiang,&nbsp;Shanshan Tang,&nbsp;Yuqian Bao,&nbsp;Kunsan Xiang,&nbsp;Weiping Jia","doi":"10.1155/2012/917496","DOIUrl":"https://doi.org/10.1155/2012/917496","url":null,"abstract":"<p><strong>Background: </strong>Apelin, the endogenous ligand for the APJ receptor, has a potent hypotensive effect via a nitric oxide-dependent mechanism in vivo. The aim of the study was to investigate the association between the common variants of apelin gene (APLN) and hypertension, which was reported recently in a Chinese Han population with and without diabetes.</p><p><strong>Methods: </strong>Three single nucleotide polymorphisms (SNPs) on APLN were genotyped in 3156 diabetic patients and 3736 nondiabetic individuals. For non-diabetic subjects, 1779 were enrolled in stage 1 and 1757 were recruited for validation. A meta-analysis combining the two stages was carried out to obtain the overall effect.</p><p><strong>Results: </strong>In diabetic patients, no significant associations of the three SNPs with hypertension were observed. In contrast, we found that rs2235306 was associated with hypertension in non-diabetic males after adjusting for covariates (OR = 1.19, P = 0.039) while rs2235307 and rs3115759 displayed no evidence of association in both genders. One haplotype, C-C-A, also showed an association with hypertension (OR = 1.47, P = 0.032) only in men. However, analysis in stage 2 and meta-analysis did not support these findings.</p><p><strong>Conclusions: </strong>We conclude that common variants on APLN are not associated with the prevalence of hypertension in the Chinese.</p>","PeriodicalId":12109,"journal":{"name":"Experimental Diabetes Research","volume":"2012 ","pages":"917496"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/917496","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31159649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Prevalence and risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes. 中国2型糖尿病患者QTc间期延长的患病率及危险因素
Pub Date : 2012-01-01 Epub Date: 2012-12-25 DOI: 10.1155/2012/234084
Xiang Li, Hui Ren, Zhang-rong Xu, Yan-jun Liu, Xiao-pin Yang, Jian-qin Liu

Objectives: The aim of this study was to evaluate the prevalence and the risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes.

Methods: The retrospective study included 3156 outpatients from the Diabetes Centre, the 306th Hospital of PLA, during the period from September 2003 to June 2010. QT interval was measured manually in the 12-lead conventional electrocardiogram. The QT interval corrected for heart rate (QTc) was calculated using Bazett's formula. Additional demographic and laboratory data were also collected. Potential risk factors of prolonged QTc interval were assessed using multivariable regression.

Results: The prevalence of prolonged QTc interval among Chinese patients with type 2 diabetes was 30.1%. Height (OR 0.156, 95% CI 0.032~0.748), waist circumference (OR 1.025, 95% CI 1.010~1.040), diastolic blood pressure (OR 1.016, 95% CI 1.007~1.026), postprandial glucose (OR 1.040, 95% CI 1.022~1.059), fasting insulin (OR 1.014, 95% CI 1.003~1.025), and presence of microalbuminuria (OR 1.266, 95% CI 1.033~1.551) were significant risk factors.

Conclusions: The prevalence of prolonged QTc interval among Chinese patients with type 2 diabetes is high. Risk factors for prolongation of QTc interval were low height, high waist circumference, increasing diastolic blood pressure levels, high postprandial glucose levels, high fasting insulin levels, and presence of microalbuminuria.

目的:本研究的目的是评估中国2型糖尿病患者QTc间期延长的患病率及其危险因素。方法:对2003年9月至2010年6月解放军第306医院糖尿病中心门诊就诊的3156例患者进行回顾性研究。12导联常规心电图人工测量QT间期。经心率校正后的QT间期(QTc)采用Bazett公式计算。还收集了额外的人口统计和实验室数据。采用多变量回归评估QTc间期延长的潜在危险因素。结果:中国2型糖尿病患者QTc间期延长的患病率为30.1%。身高(OR 0.156, 95% CI 0.032~0.748)、腰围(OR 1.025, 95% CI 1.010~1.040)、舒张压(OR 1.016, 95% CI 1.007~1.026)、餐后血糖(OR 1.040, 95% CI 1.022~1.059)、空腹胰岛素(OR 1.014, 95% CI 1.003~1.025)、微量白蛋白尿(OR 1.266, 95% CI 1.033~1.551)为显著危险因素。结论:中国2型糖尿病患者QTc间期延长的患病率较高。QTc间期延长的危险因素有:身高低、腰围高、舒张压升高、餐后血糖水平高、空腹胰岛素水平高、微量白蛋白尿。
{"title":"Prevalence and risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes.","authors":"Xiang Li,&nbsp;Hui Ren,&nbsp;Zhang-rong Xu,&nbsp;Yan-jun Liu,&nbsp;Xiao-pin Yang,&nbsp;Jian-qin Liu","doi":"10.1155/2012/234084","DOIUrl":"https://doi.org/10.1155/2012/234084","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to evaluate the prevalence and the risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes.</p><p><strong>Methods: </strong>The retrospective study included 3156 outpatients from the Diabetes Centre, the 306th Hospital of PLA, during the period from September 2003 to June 2010. QT interval was measured manually in the 12-lead conventional electrocardiogram. The QT interval corrected for heart rate (QTc) was calculated using Bazett's formula. Additional demographic and laboratory data were also collected. Potential risk factors of prolonged QTc interval were assessed using multivariable regression.</p><p><strong>Results: </strong>The prevalence of prolonged QTc interval among Chinese patients with type 2 diabetes was 30.1%. Height (OR 0.156, 95% CI 0.032~0.748), waist circumference (OR 1.025, 95% CI 1.010~1.040), diastolic blood pressure (OR 1.016, 95% CI 1.007~1.026), postprandial glucose (OR 1.040, 95% CI 1.022~1.059), fasting insulin (OR 1.014, 95% CI 1.003~1.025), and presence of microalbuminuria (OR 1.266, 95% CI 1.033~1.551) were significant risk factors.</p><p><strong>Conclusions: </strong>The prevalence of prolonged QTc interval among Chinese patients with type 2 diabetes is high. Risk factors for prolongation of QTc interval were low height, high waist circumference, increasing diastolic blood pressure levels, high postprandial glucose levels, high fasting insulin levels, and presence of microalbuminuria.</p>","PeriodicalId":12109,"journal":{"name":"Experimental Diabetes Research","volume":"2012 ","pages":"234084"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/234084","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31161738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 39
Nicotine exposure exacerbates development of cataracts in a type 1 diabetic rat model. 在1型糖尿病大鼠模型中,尼古丁暴露加剧了白内障的发展。
Pub Date : 2012-01-01 Epub Date: 2012-09-20 DOI: 10.1155/2012/349320
Nima Tirgan, Gabriela A Kulp, Praveena Gupta, Adam Boretsky, Tomasz A Wiraszka, Bernard Godley, Ronald G Tilton, Massoud Motamedi

Diabetes and smoking are known risk factors for cataract development. In this study, we evaluated the effect of nicotine on the progression of cataracts in a type 1 diabetic rat model. Diabetes was induced in Sprague-Dawley rats by a single injection of 65 mg/kg streptozotocin. Daily nicotine injections were administered subcutaneously. Forty-five rats were divided into groups of diabetics with and without nicotine treatment and controls with and without nicotine treatment. Progression of lens opacity was monitored using a slit lamp biomicroscope and scores were assigned. To assess whether systemic inflammation played a role in mediating cataractogenesis, we studied serum levels of eotaxin, IL-6, and IL-4. The levels of the measured cytokines increased significantly in nicotine-treated and untreated diabetic animals versus controls and demonstrated a positive trend in the nicotine-treated diabetic rats. Our data suggest the presence of a synergistic relationship between nicotine and diabetes that accelerated cataract formation via inflammatory mediators.

糖尿病和吸烟是白内障发展的危险因素。在这项研究中,我们评估了尼古丁对1型糖尿病大鼠模型白内障进展的影响。单次注射链脲佐菌素65 mg/kg诱导sd大鼠糖尿病。每日皮下注射尼古丁。45只大鼠被分成两组,一组是接受和不接受尼古丁治疗的糖尿病患者,另一组是接受和不接受尼古丁治疗的对照组。使用裂隙灯生物显微镜监测晶状体混浊的进展并进行评分。为了评估全身性炎症是否在介导白内障发生中起作用,我们研究了eotaxin、IL-6和IL-4的血清水平。测量的细胞因子水平在尼古丁治疗和未治疗的糖尿病动物中与对照组相比显著增加,并且在尼古丁治疗的糖尿病大鼠中显示出积极的趋势。我们的数据表明尼古丁和糖尿病之间存在协同关系,通过炎症介质加速白内障的形成。
{"title":"Nicotine exposure exacerbates development of cataracts in a type 1 diabetic rat model.","authors":"Nima Tirgan,&nbsp;Gabriela A Kulp,&nbsp;Praveena Gupta,&nbsp;Adam Boretsky,&nbsp;Tomasz A Wiraszka,&nbsp;Bernard Godley,&nbsp;Ronald G Tilton,&nbsp;Massoud Motamedi","doi":"10.1155/2012/349320","DOIUrl":"https://doi.org/10.1155/2012/349320","url":null,"abstract":"<p><p>Diabetes and smoking are known risk factors for cataract development. In this study, we evaluated the effect of nicotine on the progression of cataracts in a type 1 diabetic rat model. Diabetes was induced in Sprague-Dawley rats by a single injection of 65 mg/kg streptozotocin. Daily nicotine injections were administered subcutaneously. Forty-five rats were divided into groups of diabetics with and without nicotine treatment and controls with and without nicotine treatment. Progression of lens opacity was monitored using a slit lamp biomicroscope and scores were assigned. To assess whether systemic inflammation played a role in mediating cataractogenesis, we studied serum levels of eotaxin, IL-6, and IL-4. The levels of the measured cytokines increased significantly in nicotine-treated and untreated diabetic animals versus controls and demonstrated a positive trend in the nicotine-treated diabetic rats. Our data suggest the presence of a synergistic relationship between nicotine and diabetes that accelerated cataract formation via inflammatory mediators.</p>","PeriodicalId":12109,"journal":{"name":"Experimental Diabetes Research","volume":"2012 ","pages":"349320"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/349320","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30965369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Short-chain fatty acid propionate alleviates Akt2 knockout-induced myocardial contractile dysfunction. 短链脂肪酸丙酸减轻Akt2敲除引起的心肌收缩功能障碍。
Pub Date : 2012-01-01 Epub Date: 2011-09-22 DOI: 10.1155/2012/851717
Linlin Li, Yinan Hua, Jun Ren

BACKGROUND AND AIMS. Dysregulation of Akt has been implicated in diseases such as cancer and diabetes, although little is known about the role of Akt deficiency on cardiomyocyte contractile function. This study was designed to examine the effect of Akt2 knockout-induced cardiomyocyte contractile response and the effect of dietary supplementation of short-chain fatty acid propionate on Akt2 knockout-induced cardiac dysfunction, if any. METHODS AND RESULTS. Adult male wild-type (WT) and Akt2 knockout mice were treated with propionate (0.3 g/kg, p.o.) or vehicle for 7 days. Oral glucose tolerance test (OGTT) was performed. Cardiomyocyte contractile function and mitochondrial membrane potential were assessed. Expression of insulin-signaling molecules Akt, PTEN, GSK3β, and eNOS receptors for short-chain fatty acids GPR41, and GPR43 as well as protein phosphatase PP2AA, PP2AB, PP2C were evaluated using Western blot analysis. Our results revealed that Akt2 knockout led to overt glucose intolerance, compromised cardiomyocyte contractile function (reduced peak shortening and maximal velocity of shortening/relengthening as well as prolonged relengthening), loss of mitochondrial membrane potential, decreased GPR41 and elevated GPR43 expression, all of which, with the exception of glucose intolerance and elevated GPR43 level, were significantly attenuated by propionate. Neither Akt2 knockout nor propionate affected the expression of protein phosphatases, eNOS, pan, and phosphorylated PTEN and GSK3β. CONCLUSIONS. Taken together, these data depicted that Akt2 knockout may elicit cardiomyocyte contractile and mitochondrial defects and a beneficial role of propionate or short-chain fatty acids against Akt2 deficiency-induced cardiac anomalies.

背景和目的。Akt的失调与癌症和糖尿病等疾病有关,尽管对Akt缺乏对心肌细胞收缩功能的作用知之甚少。本研究旨在研究Akt2敲除诱导的心肌细胞收缩反应的影响,以及饮食中补充丙酸短链脂肪酸对Akt2敲除诱导的心功能障碍(如果有的话)的影响。方法与结果。野生型(WT)和Akt2基因敲除的成年雄性小鼠分别用丙酸(0.3 g/kg, p.o.)或载药治疗7天。进行口服糖耐量试验(OGTT)。评估心肌细胞收缩功能和线粒体膜电位。Western blot分析胰岛素信号分子Akt、PTEN、GSK3β和eNOS受体对短链脂肪酸GPR41、GPR43的表达以及蛋白磷酸酶PP2AA、PP2AB、PP2C的表达。我们的研究结果显示,Akt2敲除导致明显的葡萄糖不耐受,心肌细胞收缩功能受损(缩短/延长的峰值和最大速度降低以及延长的再延长时间),线粒体膜电位丧失,GPR41降低和GPR43表达升高,除了葡萄糖不耐受和GPR43水平升高外,所有这些都被丙酸显著减弱。Akt2敲除和丙酸均不影响蛋白磷酸酶、eNOS、pan以及磷酸化的PTEN和GSK3β的表达。结论。综上所述,这些数据表明Akt2基因敲除可能引发心肌细胞收缩和线粒体缺陷,丙酸或短链脂肪酸对Akt2缺陷引起的心脏异常有有益作用。
{"title":"Short-chain fatty acid propionate alleviates Akt2 knockout-induced myocardial contractile dysfunction.","authors":"Linlin Li,&nbsp;Yinan Hua,&nbsp;Jun Ren","doi":"10.1155/2012/851717","DOIUrl":"https://doi.org/10.1155/2012/851717","url":null,"abstract":"<p><p>BACKGROUND AND AIMS. Dysregulation of Akt has been implicated in diseases such as cancer and diabetes, although little is known about the role of Akt deficiency on cardiomyocyte contractile function. This study was designed to examine the effect of Akt2 knockout-induced cardiomyocyte contractile response and the effect of dietary supplementation of short-chain fatty acid propionate on Akt2 knockout-induced cardiac dysfunction, if any. METHODS AND RESULTS. Adult male wild-type (WT) and Akt2 knockout mice were treated with propionate (0.3 g/kg, p.o.) or vehicle for 7 days. Oral glucose tolerance test (OGTT) was performed. Cardiomyocyte contractile function and mitochondrial membrane potential were assessed. Expression of insulin-signaling molecules Akt, PTEN, GSK3β, and eNOS receptors for short-chain fatty acids GPR41, and GPR43 as well as protein phosphatase PP2AA, PP2AB, PP2C were evaluated using Western blot analysis. Our results revealed that Akt2 knockout led to overt glucose intolerance, compromised cardiomyocyte contractile function (reduced peak shortening and maximal velocity of shortening/relengthening as well as prolonged relengthening), loss of mitochondrial membrane potential, decreased GPR41 and elevated GPR43 expression, all of which, with the exception of glucose intolerance and elevated GPR43 level, were significantly attenuated by propionate. Neither Akt2 knockout nor propionate affected the expression of protein phosphatases, eNOS, pan, and phosphorylated PTEN and GSK3β. CONCLUSIONS. Taken together, these data depicted that Akt2 knockout may elicit cardiomyocyte contractile and mitochondrial defects and a beneficial role of propionate or short-chain fatty acids against Akt2 deficiency-induced cardiac anomalies.</p>","PeriodicalId":12109,"journal":{"name":"Experimental Diabetes Research","volume":"2012 ","pages":"851717"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/851717","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30176071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
Diabetes and nonalcoholic fatty liver disease. 糖尿病和非酒精性脂肪肝。
Pub Date : 2012-01-01 Epub Date: 2011-12-14 DOI: 10.1155/2012/404632
Konstantinos Kantartzis, Amalia Gastaldelli, Faidon Magkos, Jean-Marc Lavoie
With almost every third individual affected in the general population in industrialized countries and increasing prevalence among children and adolescents, nonalcoholic fatty liver disease (NAFLD) represents the most common cause of chronic liver diseases such as cirrhosis, liver failure, and hepatocellular carcinoma and is therefore the most common cause of liver transplantation. In addition, in recent years NAFLD has emerged as a key player in human metabolism. Several studies demonstrate that NAFLD is strongly associated with insulin resistance and precedes the manifestation of type 2 diabetes and cardiovascular disease. Of particular interest, the associations of ectopic fat accumulation in the liver with insulin resistance and type 2 diabetes are stronger than the respective of visceral and intramyocellular fat, implying that liver fat is an independent factor modifying the whole-body obesity-related metabolic risk. Thus, fatty liver may be not simply another manifestation of the metabolic syndrome, but it may itself induce or worsen insulin resistance and type 2 diabetes. In other words, fatty liver may be a determinant, not merely a marker of metabolic dysfunction. Though certainly, cause-and-effect relationships are hard to establish. It is therefore why a concerted effort of the academic disciplines is requested to study the responsible mechanisms involved in the process of hepatic fat accumulation as well as the mechanisms regulating the crosstalk between fatty liver and other tissues important for regulation of metabolism in humans. In this special issue, we have invited some papers hoping to shed light on some aspects of this very interesting field. In the first paper of this issue “Diagnosis and evaluation of nonalcoholic fatty liver disease,” epidemiology and tools for diagnosing NAFLD are reviewed. Regarding epidemiology, interesting data are provided on the interaction of NAFLD and type 2 diabetes, when concurrently present. In terms of diagnostic evaluation, of particular interest is the systematic presentation of old and novel biomarkers as well as panel markers (scores) and their sensitivity, specificity, positive and negative predictive values in estimating the amount of liver fat and differentiating more progressive forms of NAFLD, such as NASH and fibrosis, from simple steatosis. The second paper of this issue “Role of transcription factor modifications in the pathogenesis of insulin resistance,” evaluates the diverse types of posttranslational modification of transcription factors in insulin-sensitive tissues and their putative role in the pathogenesis of insulin resistance. The authors particularly focused on the liver, where a lot of transcription factors have key roles in metabolic pathways critical for the pathogenesis of hepatic insulin resistance and NAFLD. For instance, forkhead box protein 1 (FOXO1) and cAMP response element binding protein (CREB) are major transcription factors for gluconeogenic gene ex
{"title":"Diabetes and nonalcoholic fatty liver disease.","authors":"Konstantinos Kantartzis,&nbsp;Amalia Gastaldelli,&nbsp;Faidon Magkos,&nbsp;Jean-Marc Lavoie","doi":"10.1155/2012/404632","DOIUrl":"https://doi.org/10.1155/2012/404632","url":null,"abstract":"With almost every third individual affected in the general population in industrialized countries and increasing prevalence among children and adolescents, nonalcoholic fatty liver disease (NAFLD) represents the most common cause of chronic liver diseases such as cirrhosis, liver failure, and hepatocellular carcinoma and is therefore the most common cause of liver transplantation. In addition, in recent years NAFLD has emerged as a key player in human metabolism. Several studies demonstrate that NAFLD is strongly associated with insulin resistance and precedes the manifestation of type 2 diabetes and cardiovascular disease. \u0000 \u0000Of particular interest, the associations of ectopic fat accumulation in the liver with insulin resistance and type 2 diabetes are stronger than the respective of visceral and intramyocellular fat, implying that liver fat is an independent factor modifying the whole-body obesity-related metabolic risk. Thus, fatty liver may be not simply another manifestation of the metabolic syndrome, but it may itself induce or worsen insulin resistance and type 2 diabetes. In other words, fatty liver may be a determinant, not merely a marker of metabolic dysfunction. Though certainly, cause-and-effect relationships are hard to establish. \u0000 \u0000It is therefore why a concerted effort of the academic disciplines is requested to study the responsible mechanisms involved in the process of hepatic fat accumulation as well as the mechanisms regulating the crosstalk between fatty liver and other tissues important for regulation of metabolism in humans. In this special issue, we have invited some papers hoping to shed light on some aspects of this very interesting field. \u0000 \u0000In the first paper of this issue “Diagnosis and evaluation of nonalcoholic fatty liver disease,” epidemiology and tools for diagnosing NAFLD are reviewed. Regarding epidemiology, interesting data are provided on the interaction of NAFLD and type 2 diabetes, when concurrently present. In terms of diagnostic evaluation, of particular interest is the systematic presentation of old and novel biomarkers as well as panel markers (scores) and their sensitivity, specificity, positive and negative predictive values in estimating the amount of liver fat and differentiating more progressive forms of NAFLD, such as NASH and fibrosis, from simple steatosis. \u0000 \u0000The second paper of this issue “Role of transcription factor modifications in the pathogenesis of insulin resistance,” evaluates the diverse types of posttranslational modification of transcription factors in insulin-sensitive tissues and their putative role in the pathogenesis of insulin resistance. The authors particularly focused on the liver, where a lot of transcription factors have key roles in metabolic pathways critical for the pathogenesis of hepatic insulin resistance and NAFLD. For instance, forkhead box protein 1 (FOXO1) and cAMP response element binding protein (CREB) are major transcription factors for gluconeogenic gene ex","PeriodicalId":12109,"journal":{"name":"Experimental Diabetes Research","volume":"2012 ","pages":"404632"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/404632","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30346152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Diabetes and thyroid cancer risk: literature review. 糖尿病和甲状腺癌风险:文献综述。
Pub Date : 2012-01-01 Epub Date: 2012-06-12 DOI: 10.1155/2012/578285
Shyang-Rong Shih, Wei-Yih Chiu, Tien-Chun Chang, Chin-Hsiao Tseng

Diabetic patients have a higher risk of various types of cancer. However, whether diabetes may increase the risk of thyroid cancer has not been extensively studied. This paper reviews and summarizes the current literature studying the relationship between diabetes mellitus and thyroid cancer, and the possible mechanisms linking such an association. Epidemiologic studies showed significant or nonsignificant increases in thyroid cancer risk in diabetic women and nonsignificant increase or no change in thyroid cancer risk in diabetic men. A recent pooled analysis, including 5 prospective studies from the USA, showed that the summary hazard ratio (95% confidence interval) for women was 1.19 (0.84-1.69) and was 0.96 (0.65-1.42) for men. Therefore, the results are controversial and the association between diabetes and thyroid cancer is probably weak. Further studies are necessary to confirm their relationship. Proposed mechanisms for such a possible link between diabetes and thyroid cancer include elevated levels of thyroid-stimulating hormone, insulin, glucose and triglycerides, insulin resistance, obesity, vitamin D deficiency, and antidiabetic medications such as insulin or sulfonylureas.

糖尿病患者患各种癌症的风险更高。然而,糖尿病是否会增加患甲状腺癌的风险尚未得到广泛的研究。本文就糖尿病与甲状腺癌的关系及其可能的机制进行综述。流行病学研究显示,女性糖尿病患者患甲状腺癌的风险显著或不显著增加,男性糖尿病患者患甲状腺癌的风险无显著增加或无显著变化。最近的一项汇总分析,包括来自美国的5项前瞻性研究,显示女性的总风险比(95%可信区间)为1.19(0.84-1.69),男性为0.96(0.65-1.42)。因此,结果是有争议的,糖尿病和甲状腺癌之间的联系可能很弱。需要进一步的研究来证实它们之间的关系。糖尿病和甲状腺癌之间可能存在联系的机制包括促甲状腺激素、胰岛素、葡萄糖和甘油三酯水平升高、胰岛素抵抗、肥胖、维生素D缺乏以及胰岛素或磺脲类抗糖尿病药物。
{"title":"Diabetes and thyroid cancer risk: literature review.","authors":"Shyang-Rong Shih,&nbsp;Wei-Yih Chiu,&nbsp;Tien-Chun Chang,&nbsp;Chin-Hsiao Tseng","doi":"10.1155/2012/578285","DOIUrl":"https://doi.org/10.1155/2012/578285","url":null,"abstract":"<p><p>Diabetic patients have a higher risk of various types of cancer. However, whether diabetes may increase the risk of thyroid cancer has not been extensively studied. This paper reviews and summarizes the current literature studying the relationship between diabetes mellitus and thyroid cancer, and the possible mechanisms linking such an association. Epidemiologic studies showed significant or nonsignificant increases in thyroid cancer risk in diabetic women and nonsignificant increase or no change in thyroid cancer risk in diabetic men. A recent pooled analysis, including 5 prospective studies from the USA, showed that the summary hazard ratio (95% confidence interval) for women was 1.19 (0.84-1.69) and was 0.96 (0.65-1.42) for men. Therefore, the results are controversial and the association between diabetes and thyroid cancer is probably weak. Further studies are necessary to confirm their relationship. Proposed mechanisms for such a possible link between diabetes and thyroid cancer include elevated levels of thyroid-stimulating hormone, insulin, glucose and triglycerides, insulin resistance, obesity, vitamin D deficiency, and antidiabetic medications such as insulin or sulfonylureas.</p>","PeriodicalId":12109,"journal":{"name":"Experimental Diabetes Research","volume":"2012 ","pages":"578285"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/578285","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30750382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 65
Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring. 母亲糖尿病对导致后代疾病的表观遗传修饰的影响。
Pub Date : 2012-01-01 Epub Date: 2012-11-22 DOI: 10.1155/2012/538474
Nikolaos Vrachnis, Nikolaos Antonakopoulos, Zoe Iliodromiti, Konstantinos Dafopoulos, Charalambos Siristatidis, Kalliopi I Pappa, Efthymios Deligeoroglou, Nicolaos Vitoratos

Gestational diabetes, occurring during the hyperglycemic period of pregnancy in maternal life, is a pathologic state that increases the incidence of complications in both mother and fetus. Offspring thus exposed to an adverse fetal and early postnatal environment may manifest increased susceptibility to a number of chronic diseases later in life. Compelling evidence for the role of epigenetic transmission in these complications has come from comparison of siblings born before and after the development of maternal diabetes, exposure to this intrauterine diabetic environment being shown to cause alterations in fetal growth patterns which predispose these infants to developing overweight and obesity later in life. Diabetes of the offspring is also mainly the consequence of exposure to the diabetic intrauterine environment, in addition to genetic susceptibility. Since obesity and diabetes are known to increase the risk of cardiovascular disease, cardiovascular sequelae in the offspring of diabetic mothers are virtually inevitable. Research data also suggest that exposure to a diabetic intrauterine environment during pregnancy is associated with an increase in dyslipidemia, subclinical vascular inflammation, and endothelial dysfunction processes in the offspring, all of which are linked with development of cardiovascular disease later in life. The main underlying mechanisms involve persistent hyperglycemia hyperinsulinemia and leptin resistance.

妊娠期糖尿病是发生在母体生命中妊娠高血糖期的一种病理状态,可增加母胎并发症的发生率。因此,暴露于不利的胎儿和产后早期环境的后代可能在以后的生活中表现出对许多慢性病的易感性增加。表观遗传传递在这些并发症中的作用的有力证据来自于对母亲患糖尿病前后出生的兄弟姐妹的比较,暴露于这种宫内糖尿病环境会导致胎儿生长模式的改变,从而使这些婴儿在以后的生活中更容易发生超重和肥胖。除了遗传易感性外,后代的糖尿病也主要是暴露于糖尿病宫内环境的结果。由于已知肥胖和糖尿病会增加心血管疾病的风险,因此糖尿病母亲的后代患心血管疾病的后遗症几乎是不可避免的。研究数据还表明,怀孕期间暴露于糖尿病宫内环境与后代血脂异常、亚临床血管炎症和内皮功能障碍过程的增加有关,所有这些都与生命后期心血管疾病的发展有关。主要的潜在机制包括持续高血糖、高胰岛素血症和瘦素抵抗。
{"title":"Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring.","authors":"Nikolaos Vrachnis,&nbsp;Nikolaos Antonakopoulos,&nbsp;Zoe Iliodromiti,&nbsp;Konstantinos Dafopoulos,&nbsp;Charalambos Siristatidis,&nbsp;Kalliopi I Pappa,&nbsp;Efthymios Deligeoroglou,&nbsp;Nicolaos Vitoratos","doi":"10.1155/2012/538474","DOIUrl":"https://doi.org/10.1155/2012/538474","url":null,"abstract":"<p><p>Gestational diabetes, occurring during the hyperglycemic period of pregnancy in maternal life, is a pathologic state that increases the incidence of complications in both mother and fetus. Offspring thus exposed to an adverse fetal and early postnatal environment may manifest increased susceptibility to a number of chronic diseases later in life. Compelling evidence for the role of epigenetic transmission in these complications has come from comparison of siblings born before and after the development of maternal diabetes, exposure to this intrauterine diabetic environment being shown to cause alterations in fetal growth patterns which predispose these infants to developing overweight and obesity later in life. Diabetes of the offspring is also mainly the consequence of exposure to the diabetic intrauterine environment, in addition to genetic susceptibility. Since obesity and diabetes are known to increase the risk of cardiovascular disease, cardiovascular sequelae in the offspring of diabetic mothers are virtually inevitable. Research data also suggest that exposure to a diabetic intrauterine environment during pregnancy is associated with an increase in dyslipidemia, subclinical vascular inflammation, and endothelial dysfunction processes in the offspring, all of which are linked with development of cardiovascular disease later in life. The main underlying mechanisms involve persistent hyperglycemia hyperinsulinemia and leptin resistance.</p>","PeriodicalId":12109,"journal":{"name":"Experimental Diabetes Research","volume":"2012 ","pages":"538474"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/538474","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31109056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 94
Small molecule drug discovery at the glucagon-like peptide-1 receptor. 胰高血糖素样肽-1受体的小分子药物发现。
Pub Date : 2012-01-01 Epub Date: 2012-02-23 DOI: 10.1155/2012/709893
Francis S Willard, Ana B Bueno, Kyle W Sloop

The therapeutic success of peptide glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes mellitus has inspired discovery efforts aimed at developing orally available small molecule GLP-1 receptor agonists. Although the GLP-1 receptor is a member of the structurally complex class B1 family of GPCRs, in recent years, a diverse array of orthosteric and allosteric nonpeptide ligands has been reported. These compounds include antagonists, agonists, and positive allosteric modulators with intrinsic efficacy. In this paper, a comprehensive review of currently disclosed small molecule GLP-1 receptor ligands is presented. In addition, examples of "ligand bias" and "probe dependency" for the GLP-1 receptor are discussed; these emerging concepts may influence further optimization of known molecules or persuade designs of expanded screening strategies to identify novel chemical starting points for GLP-1 receptor drug discovery.

胰高血糖素样肽-1 (GLP-1)受体激动剂治疗2型糖尿病的成功,激发了开发口服小分子GLP-1受体激动剂的发现努力。虽然GLP-1受体是结构复杂的B1类gpcr家族的成员,但近年来,各种各样的正构和变构非肽配体被报道。这些化合物包括具有内在功效的拮抗剂、激动剂和正变构调节剂。本文对目前发现的小分子GLP-1受体配体进行了综述。此外,还讨论了GLP-1受体的“配体偏倚”和“探针依赖”的例子;这些新出现的概念可能会影响已知分子的进一步优化或说服扩大筛选策略的设计,以确定GLP-1受体药物发现的新化学起点。
{"title":"Small molecule drug discovery at the glucagon-like peptide-1 receptor.","authors":"Francis S Willard,&nbsp;Ana B Bueno,&nbsp;Kyle W Sloop","doi":"10.1155/2012/709893","DOIUrl":"https://doi.org/10.1155/2012/709893","url":null,"abstract":"<p><p>The therapeutic success of peptide glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes mellitus has inspired discovery efforts aimed at developing orally available small molecule GLP-1 receptor agonists. Although the GLP-1 receptor is a member of the structurally complex class B1 family of GPCRs, in recent years, a diverse array of orthosteric and allosteric nonpeptide ligands has been reported. These compounds include antagonists, agonists, and positive allosteric modulators with intrinsic efficacy. In this paper, a comprehensive review of currently disclosed small molecule GLP-1 receptor ligands is presented. In addition, examples of \"ligand bias\" and \"probe dependency\" for the GLP-1 receptor are discussed; these emerging concepts may influence further optimization of known molecules or persuade designs of expanded screening strategies to identify novel chemical starting points for GLP-1 receptor drug discovery.</p>","PeriodicalId":12109,"journal":{"name":"Experimental Diabetes Research","volume":"2012 ","pages":"709893"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/709893","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30631235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 69
Mitochondrial dysregulation in the pathogenesis of diabetes: potential for mitochondrial biogenesis-mediated interventions. 糖尿病发病机制中的线粒体失调:线粒体生物发生介导干预的潜力。
Pub Date : 2012-01-01 Epub Date: 2011-12-01 DOI: 10.1155/2012/642038
Anna-Maria Joseph, Denis R Joanisse, Richard G Baillot, David A Hood

Muscle mitochondrial metabolism is a tightly controlled process that involves the coordination of signaling pathways and factors from both the nuclear and mitochondrial genomes. Perhaps the most important pathway regulating metabolism in muscle is mitochondrial biogenesis. In response to physiological stimuli such as exercise, retrograde signaling pathways are activated that allow crosstalk between the nucleus and mitochondria, upregulating hundreds of genes and leading to higher mitochondrial content and increased oxidation of substrates. With type 2 diabetes, these processes can become dysregulated and the ability of the cell to respond to nutrient and energy fluctuations is diminished. This, coupled with reduced mitochondrial content and altered mitochondrial morphology, has been directly linked to the pathogenesis of this disease. In this paper, we will discuss our current understanding of mitochondrial dysregulation in skeletal muscle as it relates to type 2 diabetes, placing particular emphasis on the pathways of mitochondrial biogenesis and mitochondrial dynamics, and the therapeutic value of exercise and other interventions.

肌肉线粒体代谢是一个受到严格控制的过程,涉及核基因组和线粒体基因组的信号通路和因子的协调。也许调节肌肉代谢最重要的途径是线粒体生物发生。作为对运动等生理刺激的反应,逆行信号通路被激活,允许细胞核和线粒体之间的串扰,上调数百个基因,导致线粒体含量增加和底物氧化增加。患有2型糖尿病,这些过程可能变得失调,细胞对营养和能量波动的反应能力减弱。这一点,再加上线粒体含量减少和线粒体形态改变,与这种疾病的发病机制直接相关。在本文中,我们将讨论我们目前对骨骼肌线粒体失调的理解,因为它与2型糖尿病有关,特别强调线粒体生物发生和线粒体动力学的途径,以及运动和其他干预措施的治疗价值。
{"title":"Mitochondrial dysregulation in the pathogenesis of diabetes: potential for mitochondrial biogenesis-mediated interventions.","authors":"Anna-Maria Joseph,&nbsp;Denis R Joanisse,&nbsp;Richard G Baillot,&nbsp;David A Hood","doi":"10.1155/2012/642038","DOIUrl":"https://doi.org/10.1155/2012/642038","url":null,"abstract":"<p><p>Muscle mitochondrial metabolism is a tightly controlled process that involves the coordination of signaling pathways and factors from both the nuclear and mitochondrial genomes. Perhaps the most important pathway regulating metabolism in muscle is mitochondrial biogenesis. In response to physiological stimuli such as exercise, retrograde signaling pathways are activated that allow crosstalk between the nucleus and mitochondria, upregulating hundreds of genes and leading to higher mitochondrial content and increased oxidation of substrates. With type 2 diabetes, these processes can become dysregulated and the ability of the cell to respond to nutrient and energy fluctuations is diminished. This, coupled with reduced mitochondrial content and altered mitochondrial morphology, has been directly linked to the pathogenesis of this disease. In this paper, we will discuss our current understanding of mitochondrial dysregulation in skeletal muscle as it relates to type 2 diabetes, placing particular emphasis on the pathways of mitochondrial biogenesis and mitochondrial dynamics, and the therapeutic value of exercise and other interventions.</p>","PeriodicalId":12109,"journal":{"name":"Experimental Diabetes Research","volume":"2012 ","pages":"642038"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/642038","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30353515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 113
Increased caspase-3 immunoreactivity of erythrocytes in STZ diabetic rats. STZ糖尿病大鼠红细胞caspase-3免疫反应性增高。
Pub Date : 2012-01-01 Epub Date: 2012-04-26 DOI: 10.1155/2012/316384
Uğur Fırat, Savaş Kaya, Abdullah Cim, Hüseyin Büyükbayram, Osman Gökalp, Mehmet Sinan Dal, Mehmet Numan Tamer

Eryptosis is a term to define apoptosis of erythrocytes. Oxidative stress and hyperglycemia, both of which exist in the diabetic intravascular environment, can trigger eryptosis of erythrocytes. In this experimental study, it is presented that the majority of erythrocytes shows caspase-3 immunoreactivity in streptozocin- (STZ)-induced diabetic rats. Besides that, caspase-3 positive erythrocytes are aggregated and attached to vascular endothelium. In conclusion, these results may start a debate that eryptosis could have a role in the diabetic complications.

红细胞凋亡是红细胞凋亡的一个术语。氧化应激和高血糖都存在于糖尿病的血管内环境中,可引起红细胞淤积。在本实验研究中,我们发现STZ诱导的糖尿病大鼠大部分红细胞表现出caspase-3免疫反应性。此外,caspase-3阳性红细胞聚集并附着于血管内皮。总之,这些结果可能会引发一场争论,即睑下垂可能在糖尿病并发症中起作用。
{"title":"Increased caspase-3 immunoreactivity of erythrocytes in STZ diabetic rats.","authors":"Uğur Fırat,&nbsp;Savaş Kaya,&nbsp;Abdullah Cim,&nbsp;Hüseyin Büyükbayram,&nbsp;Osman Gökalp,&nbsp;Mehmet Sinan Dal,&nbsp;Mehmet Numan Tamer","doi":"10.1155/2012/316384","DOIUrl":"https://doi.org/10.1155/2012/316384","url":null,"abstract":"<p><p>Eryptosis is a term to define apoptosis of erythrocytes. Oxidative stress and hyperglycemia, both of which exist in the diabetic intravascular environment, can trigger eryptosis of erythrocytes. In this experimental study, it is presented that the majority of erythrocytes shows caspase-3 immunoreactivity in streptozocin- (STZ)-induced diabetic rats. Besides that, caspase-3 positive erythrocytes are aggregated and attached to vascular endothelium. In conclusion, these results may start a debate that eryptosis could have a role in the diabetic complications.</p>","PeriodicalId":12109,"journal":{"name":"Experimental Diabetes Research","volume":"2012 ","pages":"316384"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/316384","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30631233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 61
期刊
Experimental Diabetes Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1